2017 Impact of Pulmonary Vasodilator Device Safety on Institutional Risk and Quality

This course focuses on the methods of assessing inhaled pulmonary vasodilator delivery devices and the professional responsibilities of respiratory therapists when administering inhaled pulmonary vasodilators. This manuscript is based upon a live presentation from AARC Congress 2015.

This course is approved for 1.0 CRCE.

This course is sponsored by an unrestricted educational grant from

Seminar Information
Seminar Date:
January 10, 2017
Expiration Date:
December 31, 2017 11:59 PM
Seminar Objectives
  • Discuss the pathophysiology of pulmonary hypertension
  • Identify the treatment options for pulmonary hypertension
  • Discuss considerations impacting the selection of delivery devices for inhaled pulmonary vasodilators
  • Identify appropriate monitoring considerations for delivery devices used for inhaled pulmonary vasodilators
Impact of Pulmonary Vasodilator Device Safety on Institutional Risk and Quality

This course focuses on the methods of assessing inhaled pulmonary vasodilator delivery devices and the professional responsibilities of respiratory therapists when administering inhaled pulmonary vasodilators. 

Please view the short video and then access the manuscript by clicking on the "papers" tab above the video player. 

Speaker Information
Rich Branson MSc, RRT, FAARC  [ view bio ]
Garry Kauffman MPA, RRT, FAARC, FACHE  [ view bio ]
Individual topic purchase: Selected
American Association for Respiratory Care
Continuing Respiratory Care Education: 1.00
Products
This seminar is no longer available for purchase.